Northeastern Reproductive Medicine

Vermont Fertility Services Including IVF, Egg Donation and Fertility Preservation

  • Patient Portal
  • Donor Portal
  • 1 (802) 655-8888

Schedule A Consultation
  • Home
  • About
    • About Us
    • Our Physicians
    • Meet Our Team
    • Our Facilities
      • Laboratory
      • Ultrasound
  • Services
    • Fertility Testing
    • Basic Fertility Treatment
    • Carrier Screening
    • In Vitro Fertilization (IVF)
      • Intra-Cytoplasmic Sperm Injection (ICSI)
    • Pre-Implantation Genetic Screening and Diagnosis
    • Gender Selection
    • Donor Egg IVF – Overview for Intended Parents
    • Gestational Surrogate
    • LGBTQAI+ Family Building
    • Fertility Preservation
  • Success Stories
  • Financial Info
    • Insurance Information
    • Payments
  • Patient Info
    • Unexplained Infertility
    • Fertility Preservation
    • Bloodwork Screening Protocol
    • Genetic Carrier Screening
    • Letrozole
    • Antidepressant Use in Pregnancy
    • Understanding Recurrent Pregnancy
    • Thyroid Function in Pregnancy
    • Embryo Grading and Development
    • Varicella and Immunity
    • Rubella and Immunity
    • Female Fertility Supplements
    • Male Fertility Supplements
    • Vitamin D
    • Third Party Reproduction
    • Egg Donor Options
    • Gestational Carriers FAQs
    • Cytomegalovirus FAQs
    • Traveling to Vermont
    • Canadian Patients
    • Join Our Fertiility Family
    • FAQs
  • Egg Donors
    • Overview for Intended Parents
    • Overview for Donors
    • Donor Submission Form
  • Blog
  • Contact

Letrozole for PCOS

Posted May 14, 2015 by NRM

Letrozole is an aromatase inhibitor used to induce ovulation in patients with irregular menses or no menses at all. Letrozole works to induce ovulation by blocking estrogen production, leading to increases in follicle-stimulating hormone (FSH) release.  You may be prescribed this medication if you have polycystic ovary syndrome (PCOS) or problems with ovulation.

The use of letrozole for ovulation induction is off-label, meaning the FDA has not approved this indication. However, letrozole use for fertility has been widely studied. Most recently, the National Institutes of Health evaluated the effect of letrozole in patients with ovulatory infertility or PCOS. Dr Peter Casson was one of the principal investigators of this national, multi-center, randomized-controlled trial published in the New England Journal of Medicine that analyzed letrozole head to head with another commonly used medication, clomiphene citrate, and found letrozole to be superior.

Who may be a candidate for letrozole?

  1. Patients with PCOS or ovulatory infertility.
  2. Patients with other types of infertility that have side effects or contraindications to Clomid.

What is the success rate?

Success rates differ by female age and fertility diagnosis. In general, successful ovulation occurs in 60% of cycles, and live birth rate for patients with PCOS who are <35 years old is 15-17% per cycle.

What about twins? Triplets?

The risk of twins with letrozole is estimated to be approximately 3-5%, which appears to be lower than the risk of twins with clomiphene citrate (7-8%), but is still higher than the risk of twins in a spontaneous pregnancy (2-3%).   Although triplets and higher-order pregnancies are rare, these may occur <1% of the time.

What are the side effects?

The most commonly reported side effects of short-term use include fatigue or dizziness, which occur in approximately 10-20% of patients.

Is the risk of birth defects increased?

Letrozole may increase the risk of birth defects if taken when pregnant. Therefore, all patients need a blood draw to check B-hCG and progesterone levels prior to starting the medication.

The use of letrozole prior to pregnancy (as utilized for ovulation induction) has also been studied to evaluate the risk of birth defects.

  • One study compared the incidence of birth defects in 911 newborns of women conceived following letrozole or clomiphene citrate did not find a difference between the two groups. The rate of birth defects in the study was 2.5-5%, consistent with the national rate of birth defects for all women trying to conceive with or without infertility. (Tulandi, Fertility and Sterility, 2006).
  • In the NIH trial described earlier, the rate of birth defects was not significantly different between letrozole and clomiphene citrate patients (4.9% of 102 infants, and 1.5% of 66 infants, respectively). (Legro et al, New England Journal of Medicine, 2014).

How is letrozole taken?

This medication is typically taken for 5 days, starting on the 3rd to 5th day of your menstrual cycle.  Doses start at 2.5 mg daily. Your NRM physician will create your treatment plan based on your diagnosis and medical history.

Filed Under: Female Infertility

Recent Posts

  • NRM Partners with Ovation
  • Should you get the COVID Vaccine?
  • NRM Re-Opens May 4th
  • NRM doctors caring for patients via Telemedicine
  • Reproductive Medicine Update! NEFS Annual Meeting 2019

Categories

  • Egg Freezing
  • Fertility Clinic
  • Fertility Tips
  • Fertility Treatment Options
  • Gestational Surrogates
  • NRM News
  • Patient Education
    • Endocrine Disorders
    • Female Infertility
    • IVF and Other Advanced Reproductive Technologies
    • LGBT
    • Male Infertility
    • Natural Fertility
    • Other
    • PCOS
    • Recurrent Pregnancy Loss
  • Reproductive Pearls
  • Stories and Updates
  • Who are we?
    • Meet our doctors

Fertility Preservation Services

NRM offers freezing and storage of eggs, sperm, or embryos for individuals with a recent cancer diagnosis who desire future fertility, or those who elect to delay childbearing for other reasons.

  • Egg Freeze
  • Sperm Freeze

Referring Providers: Did you Know?

We want to work with you toward a common shared goal: maximizing reproductive health and increasing patients’ potential for successful pregnancies. We offer a set of referral services designed to help your patients take the first steps of fertility treatment Learn More.

Northeastern Reproductive Medicine

105 West View Road Suite 302
Colchester, Vermont 05446
1 (802) 655-8888

nrm-map

ASRM
Royal College
ABOG
ACOG
resolve
College of American Pathologists
Health First

  • Patient Portal
  • Donor Portal


Copyright © 2023 · Northeastern Reproductive Medicine — 105 West View Road Suite 302, Colchester, Vermont 05446